DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will issue its
third-quarter 2016 financial results before the market opens on
Wednesday, November 2, 2016. The earnings release and accompanying
financial information will be posted on the QuintilesIMS Investor
Relations website at http://ir.quintilesims.com.
The QuintilesIMS management team will host a conference call and webcast
to discuss the company’s results at 9:00 a.m. Eastern Time on November
2. Interested parties are invited to listen to the live event and view
the presentation slides via webcast on the QuintilesIMS Investor
Relations website at http://ir.quintilesims.com.
The discussion also will be available by dialing +1-800-694-4033 in the
U.S. and Canada, or +1-303-223-4393 for international callers.
A replay of the webcast will be available approximately two hours after
the conclusion of the live event on November 2. To access the webcast
recording, visit http://ir.quintilesims.com.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated to
helping its clients improve their clinical, scientific and commercial
results. Formed through the merger of Quintiles and IMS Health,
QuintilesIMS’s approximately 50,000 employees conduct operations in more
than 100 countries. Companies seeking to improve real-world patient
outcomes and enhanced clinical trial outsourcing through treatment
innovations, care provision and access can leverage QuintilesIMS’s broad
range of healthcare information, technology and service solutions to
drive new insights and approaches. QuintilesIMS provides solutions that
span clinical to commercial bringing clients a unique opportunity to
realize the full potential of innovations and advance healthcare
outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS protects
individual privacy while managing information to drive healthcare
forward. These insights and execution capabilities help biotech, medical
device, and pharmaceutical companies, medical researchers, government
agencies, payers and other healthcare stakeholders in the development
and approval of new therapies, identify unmet treatment needs and
understand the safety, effectiveness and value of pharmaceutical
products in improving overall health outcomes. To learn more, visit www.quintilesims.com/.
QUINTILESIMSFIN
Click
here to subscribe to Mobile Alerts for QuintilesIMS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161019006290/en/
Source: QuintilesIMS